Rapid Development of Post-radiotherapy Sarcoma and Breast Cancer in a Patient with a Novel Germline 'De-Novo' TP53 Mutation

We describe a novel 'de novo' TP53 mutation and discuss the importance of molecular testing in early-onset breast cancer patients and its effect on the management and outcome of the disease.